SCHEMBL7680256

SCHEMBL7680256

Cc1oc(-c2ccc(C(F)(F)F)cc2)nc1CCOc1ccc(C[C@H](N)C(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.63
PPARA Q07869 15/20 0.63
PPARD Q03181 3/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7674267 0.91 PPARG (0.71) PPARGPPARAPPARD
SCHEMBL6604087 0.89 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL5173961 0.88 PPARG (0.77) PPARGPPARAPPARD
Hydrochloric Acid SCHEMBL6276718 0.88 PPARG (0.75) PPARGPPARAPPARD
Hydrochloric Acid SCHEMBL6276712 0.88 PPARG (0.75) PPARGPPARAPPARD
SCHEMBL7676889 0.87 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL27568087 0.85 PPARG (0.71) PPARGPPARAPPARD
SCHEMBL6608605 0.85 PPARG (0.71) PPARGPPARAPPARD
SCHEMBL6281440 0.84 PPARG (0.65) PPARGPPARAPPARD
SCHEMBL6281446 0.84 PPARG (0.65) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6498174-B1 AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME SMITHKLINE BEECHAM CORPORATION 2002-12-24 US disclosed